日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Chronic myeloid leukaemia: have basophils gone the way of the Dodo bird?

慢性粒细胞白血病:嗜碱性粒细胞是否已经像渡渡鸟一样灭绝了?

Turcsanyi, Lucia; Zhang, Xiao-Shuai; Kudelka, Milos; Kubikova, Kristyna; Radvansky, Martin; Yang, Sen; Kriegova, Eva; Juranova, Jarmila; Mayer, Jiri; Klamova, Hana; Belohlavkova, Petra; Karas, Michal; Stejskal, Lukas; Cmunt, Eduard; Othus, Megan; Gale, Robert Peter; Jiang, Qian; Faber, Edgar

Laboratory Evaluation of a Wearable Instrumented Headband for Rotational Head Kinematics Measurement

对用于旋转头部运动学测量的可穿戴式仪器化头带进行实验室评估

Tripathi, Anu; Wan, Yang; Malave, Sushant; Turcsanyi, Sheila; Fawzi, Alice Lux; Brooks, Alison; Kesari, Haneesh; Snedden, Traci; Ferrazzano, Peter; Franck, Christian; Carlsen, Rika Wright

Multiple sclerosis relapse risk factors across treatment eras

多发性硬化症复发风险因素在不同治疗时期

Madill, Evan; Healy, Brian; Polgar-Turcsanyi, Mariann; Chitnis, Tanuja

Effect of Early Treatment Intensity on Progression Independent of Relapse Activity and Disability Accumulation in Multiple Sclerosis

早期治疗强度对多发性硬化症进展的影响独立于复发活动和残疾累积

Ye, Jessica Jane; Molazedeh, Negar; Polgar-Turcsanyi, Mariann; Chitnis, Tanuja

Serum glial fibrillary acidic protein predicts disease progression in multiple sclerosis

血清胶质纤维酸性蛋白可预测多发性硬化症的疾病进展

Madill, Evan; Healy, Brian C; Molazadeh, Negar; Polgar-Turcsanyi, Mariann; Glanz, Bonnie I; Weiner, Howard L; Chitnis, Tanuja

Early miR-320b and miR-25-3p miRNA levels correlate with multiple sclerosis severity at 10 years: a cohort study

早期 miR-320b 和 miR-25-3p miRNA 水平与 10 年时多发性硬化症的严重程度相关:一项队列研究

Gonzalez-Martinez, Alicia; Bose, Gauruv; Lokhande, Hrishikesh; Saxena, Shrishti; Healy, Brian C; Polgar-Turcsanyi, Mariann; Weiner, Howard L; Chitnis, Tanuja

miRNA 548a-3p as biomarker of NEDA-3 at 2 years in multiple sclerosis patients treated with fingolimod

miRNA 548a-3p 作为芬戈莫德治疗多发性硬化症患者 2 年时 NEDA-3 的生物标志物

Alicia Gonzalez-Martinez, Rohit Patel, Brian C Healy, Hrishikesh Lokhande, Anu Paul, Shrishti Saxena, Mariann Polgar-Turcsanyi, Howard L Weiner, Tanuja Chitnis

Serum GFAP and NfL Levels Differentiate Subsequent Progression and Disease Activity in Patients With Progressive Multiple Sclerosis

血清GFAP和NfL水平可区分进行性多发性硬化症患者的后续进展和疾病活动性

Barro, Christian; Healy, Brian C; Liu, Yanqing; Saxena, Shrishti; Paul, Anu; Polgar-Turcsanyi, Mariann; Guttmann, Charles R G; Bakshi, Rohit; Kropshofer, Harald; Weiner, Howard L; Chitnis, Tanuja

Multiple sclerosis lesions that impair memory map to a connected memory circuit

多发性硬化症中损害记忆的病变与相关的记忆回路相连。

Kletenik, Isaiah; Cohen, Alexander L; Glanz, Bonnie I; Ferguson, Michael A; Tauhid, Shahamat; Li, Jing; Drew, William; Polgar-Turcsanyi, Mariann; Palotai, Miklos; Siddiqi, Shan H; Marshall, Gad A; Chitnis, Tanuja; Guttmann, Charles R G; Bakshi, Rohit; Fox, Michael D

Humoral response to COVID-19 vaccination in MS patients on disease modifying therapy: Immune profiles and clinical outcomes

接受疾病修饰疗法的多发性硬化症患者接种新冠疫苗后的体液免疫反应:免疫特征和临床结果

Holroyd, Kathryn B; Healy, Brian C; Conway, Sarah; Houtchens, Maria; Bakshi, Rohit; Bhattacharyya, Shamik; Bose, Gauruv; Galetta, Kristin; Kaplan, Tamara; Severson, Christopher; Singhal, Tarun; Stazzone, Lynn; Zurawski, Jonathan; Polgar-Turcsanyi, Mariann; Saxena, Shrishti; Paul, Anu; Glanz, Bonnie I; Weiner, Howard L; Chitnis, Tanuja